Physician profile
Rayji Tsutsui
NPI 1861747255
$100,427.64
in general payments reported to CMS, 2019-2025
23 companies · $27K in 2025
The $27K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,563 · 2020: $2,335 · 2021: $464 · 2022: $7,520 · 2023: $32K · 2024: $28K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Travel and Lodging: $25K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,860.00 |
| Travel and Lodging | $25,417.98 |
| Food and Beverage | $15,026.78 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,240.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $36,408.19 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Edwards Lifesciences Corporation | $28,581.32 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $12,670.53 | 2019-2025 | Watchman, Watchman Access System, Watchman Flx |
| Philips North America LLC | $9,766.33 | 2022-2025 | (9520) Igt Devices Undivided, (8328) Image Guided Therapy Devices _ Therapy, Coronary Other |
| Abbott Laboratories | $4,793.82 | 2019-2025 | Dragonfly Opstar, Mitraclip, Triclip |
| Abiomed | $3,624.93 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $2,183.81 | 2019-2020 | |
| Medtronic, INC. | $901.35 | 2021-2025 | Corevalve Evolut R, Selectsecure, Cobalt Dr Mri Surescan |
| Teleflex LLC | $762.71 | 2025 | Manta, Turnpike, Guideliner |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.47 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $99.99 | 2020 | |
| Terumo Medical Corporation | $91.63 | 2025 | Tr Band, Angio-Seal |
| Lantheus Medical Imaging, INC. | $90.02 | 2020-2024 | Definity |
| Biotronik INC. | $76.87 | 2025 | Orsiro Mission |
| Biosense Webster, INC. | $73.98 | 2024-2025 | Nuvision Ice Catheter, Qdot Micro Catheter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $68.99 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $43.32 | 2022-2023 | Eliquis |
| Asahi Intecc USA, INC. | $19.67 | 2019 | |
| Livanova USA, INC. | $15.81 | 2019 | |
| Siemens Medical Solutions USA, INC. | $15.76 | 2019 | |
| Chiesi USA, INC. | $13.12 | 2022 | |
| Cardiovascular Systems INC. | $4.02 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rayji Tsutsui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.